PYRIMIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING SAME AS ACTIVE INGREDIENT

PYRIMIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING SAME AS ACTIVE INGREDIENT

A pyrimidine derivative, a method for preparing the pyrimidine derivative, and a pharmaceutical composition comprising the pyrimidine derivative are disclosed. Also disclosed is a method for preventing or treating cancer which includes administering the pyrimidine derivative or a composition contain...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DUGGIRALA, Krishna Babu, CHOI, Gil Don, LEE, Yujin, LEE, Kwangho, JUNG, Myoung Eun, CHAE, Chong Hak, CHO, Byoung Chul
Format: Patent
Sprache:eng
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator DUGGIRALA, Krishna Babu
CHOI, Gil Don
LEE, Yujin
LEE, Kwangho
JUNG, Myoung Eun
CHAE, Chong Hak
CHO, Byoung Chul
description A pyrimidine derivative, a method for preparing the pyrimidine derivative, and a pharmaceutical composition comprising the pyrimidine derivative are disclosed. Also disclosed is a method for preventing or treating cancer which includes administering the pyrimidine derivative or a composition containing the pyrimidine derivative to a subject in need of cancer treatment or prevention. The pyrimidine derivative exhibits a high inhibitory ability against EGFR mutation and HER2 mutation, and thus can be effectively used in treatment of cancer in which EGFR mutation and HER2 mutation have occurred
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2024343694A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2024343694A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2024343694A13</originalsourceid><addsrcrecordid>eNqNjc0KwkAMhHvxIOo7BLwqqC2Cx7AbbcD9IbsteCpF1pOooO_i61qLvXvKZGa-ZJy9_UnYsGZLoEm4xsg1LcBQLJ2GvRPwQh6F7QECmi5Cq8GXKAYVVZEVHkE5413gyM4OSE02fplui0LYa4VWkfRt4TBcBAyA6vsWOktIc4dOs9GlvT7T7Dcn2XxPUZXL9Lg36floz-mWXk0VNqtNkRf5dlfgOv-v9QE-20OP</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PYRIMIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING SAME AS ACTIVE INGREDIENT</title><source>esp@cenet</source><creator>DUGGIRALA, Krishna Babu ; CHOI, Gil Don ; LEE, Yujin ; LEE, Kwangho ; JUNG, Myoung Eun ; CHAE, Chong Hak ; CHO, Byoung Chul</creator><creatorcontrib>DUGGIRALA, Krishna Babu ; CHOI, Gil Don ; LEE, Yujin ; LEE, Kwangho ; JUNG, Myoung Eun ; CHAE, Chong Hak ; CHO, Byoung Chul</creatorcontrib><description>A pyrimidine derivative, a method for preparing the pyrimidine derivative, and a pharmaceutical composition comprising the pyrimidine derivative are disclosed. Also disclosed is a method for preventing or treating cancer which includes administering the pyrimidine derivative or a composition containing the pyrimidine derivative to a subject in need of cancer treatment or prevention. The pyrimidine derivative exhibits a high inhibitory ability against EGFR mutation and HER2 mutation, and thus can be effectively used in treatment of cancer in which EGFR mutation and HER2 mutation have occurred</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20241017&amp;DB=EPODOC&amp;CC=US&amp;NR=2024343694A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20241017&amp;DB=EPODOC&amp;CC=US&amp;NR=2024343694A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DUGGIRALA, Krishna Babu</creatorcontrib><creatorcontrib>CHOI, Gil Don</creatorcontrib><creatorcontrib>LEE, Yujin</creatorcontrib><creatorcontrib>LEE, Kwangho</creatorcontrib><creatorcontrib>JUNG, Myoung Eun</creatorcontrib><creatorcontrib>CHAE, Chong Hak</creatorcontrib><creatorcontrib>CHO, Byoung Chul</creatorcontrib><title>PYRIMIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING SAME AS ACTIVE INGREDIENT</title><description>A pyrimidine derivative, a method for preparing the pyrimidine derivative, and a pharmaceutical composition comprising the pyrimidine derivative are disclosed. Also disclosed is a method for preventing or treating cancer which includes administering the pyrimidine derivative or a composition containing the pyrimidine derivative to a subject in need of cancer treatment or prevention. The pyrimidine derivative exhibits a high inhibitory ability against EGFR mutation and HER2 mutation, and thus can be effectively used in treatment of cancer in which EGFR mutation and HER2 mutation have occurred</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjc0KwkAMhHvxIOo7BLwqqC2Cx7AbbcD9IbsteCpF1pOooO_i61qLvXvKZGa-ZJy9_UnYsGZLoEm4xsg1LcBQLJ2GvRPwQh6F7QECmi5Cq8GXKAYVVZEVHkE5413gyM4OSE02fplui0LYa4VWkfRt4TBcBAyA6vsWOktIc4dOs9GlvT7T7Dcn2XxPUZXL9Lg36floz-mWXk0VNqtNkRf5dlfgOv-v9QE-20OP</recordid><startdate>20241017</startdate><enddate>20241017</enddate><creator>DUGGIRALA, Krishna Babu</creator><creator>CHOI, Gil Don</creator><creator>LEE, Yujin</creator><creator>LEE, Kwangho</creator><creator>JUNG, Myoung Eun</creator><creator>CHAE, Chong Hak</creator><creator>CHO, Byoung Chul</creator><scope>EVB</scope></search><sort><creationdate>20241017</creationdate><title>PYRIMIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING SAME AS ACTIVE INGREDIENT</title><author>DUGGIRALA, Krishna Babu ; CHOI, Gil Don ; LEE, Yujin ; LEE, Kwangho ; JUNG, Myoung Eun ; CHAE, Chong Hak ; CHO, Byoung Chul</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2024343694A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>DUGGIRALA, Krishna Babu</creatorcontrib><creatorcontrib>CHOI, Gil Don</creatorcontrib><creatorcontrib>LEE, Yujin</creatorcontrib><creatorcontrib>LEE, Kwangho</creatorcontrib><creatorcontrib>JUNG, Myoung Eun</creatorcontrib><creatorcontrib>CHAE, Chong Hak</creatorcontrib><creatorcontrib>CHO, Byoung Chul</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DUGGIRALA, Krishna Babu</au><au>CHOI, Gil Don</au><au>LEE, Yujin</au><au>LEE, Kwangho</au><au>JUNG, Myoung Eun</au><au>CHAE, Chong Hak</au><au>CHO, Byoung Chul</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PYRIMIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING SAME AS ACTIVE INGREDIENT</title><date>2024-10-17</date><risdate>2024</risdate><abstract>A pyrimidine derivative, a method for preparing the pyrimidine derivative, and a pharmaceutical composition comprising the pyrimidine derivative are disclosed. Also disclosed is a method for preventing or treating cancer which includes administering the pyrimidine derivative or a composition containing the pyrimidine derivative to a subject in need of cancer treatment or prevention. The pyrimidine derivative exhibits a high inhibitory ability against EGFR mutation and HER2 mutation, and thus can be effectively used in treatment of cancer in which EGFR mutation and HER2 mutation have occurred</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2024343694A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title PYRIMIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING SAME AS ACTIVE INGREDIENT
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T19%3A05%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DUGGIRALA,%20Krishna%20Babu&rft.date=2024-10-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2024343694A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true